evp-0962

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2012 (NCT01661673)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • evp-0962

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01661673Phase 2Nov 1, 2012FORUM Pharmaceuticals Inc, Parexel
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
FORUM Pharmaceuticals IncFor profit1112012
ParexelFor profit1012012
2 organizations
Page 1 / 1